Expression of the SIBLINGs and their MMP partners in human benign and malignant prostate neoplasms

Charles C. Anunobi; Komal Koli; Geetu Saxena; Adekunbiola A. Banjo; Kalu U.E. Ogbureke

doi:10.18632/oncotarget.10110

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Expression of the SIBLINGs and their MMP partners in human benign and malignant prostate neoplasms

Charles C. Anunobi, Komal Koli, Geetu Saxena, Adekunbiola A. Banjo and Kalu U.E. Ogbureke _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:48038-48049. https://doi.org/10.18632/oncotarget.10110

Metrics: PDF 1526 views | HTML 2055 views | ?

Abstract

Charles C. Anunobi1, Komal Koli2, Geetu Saxena2, Adekunbiola A. Banjo1, Kalu U.E. Ogbureke2

1Department of Anatomic and Molecular Pathology, College of Medicine, University of Lagos, Lagos, Nigeria

2Department of Diagnostic and Biomedical Sciences, The University of Texas Health Science Center at Houston, School of Dentistry, Houston, Texas, U.S.A

Correspondence to:

Kalu U.E. Ogbureke, email: [email protected]

Keywords: SIBLINGs, dentin sialophosphoprotein, prostate cancer, matrix metalloproteinases, SIBLING-MMP interaction

Received: September 29, 2015 Accepted: June 04, 2016 Published: June 16, 2016

ABSTRACT

The small integrin binding ligands n-linked glycoproteins (SIBLINGs) have emerged as potential diagnostic and prognostic indices, and as key targets, in cancer therapy. Three members of the SIBLING family: bone sialoprotein (BSP); osteopontin (OPN); and dentin matrix protein1 (DMP1), bind and interact with specific matrix metalloproteinases (MMPs): BSP-MMP2; OPN-MMP3; DMP1-MMP9, in biochemical and biologic systems. The other two family members are dentin sialophosphoprotein (DSPP) and matrix extracellular phosphoglycoprotein (MEPE). The specific SIBLING-MMP pairing reported in some cancers have not been reported in prostate neoplasms. In this study, we investigated SIBLING-MMP expression and potential interaction in prostate neoplasms. Chi square analysis of immunohistochemistry results showed significant upregulation of OPN (X²=25.710/p<0.001), BSP (X²=19.546/p<0.001), and DSPP (X²=8.720/p=0.003) in prostate adenocarcinoma (pAdC). MEPE was significantly upregulated in benign prostate hyperplasia (BPH; X²=44.153/p<0.001). There were no significant differences in MMP expression between BPH and pAdC. Western blot analysis showed significantly elevated BSP and DSPP in prostate cancer-derived cells. Immunofluorescence studies confirmed BSP-MMP2, OPN-MMP3, and DMP1-MMP9 coexpression in two cancer-derived cell lines, whereas in situ proximity ligation assays confirmed potential BSP-MMP2, OPN-MMP3, and DMP1-MMP9 interactions in BPH and pAdC. Our reports provide evidence that SIBLING-MMP interaction may play a role in the progression of BPH to pAdC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10110

Publication Alerts

Research Papers:

Expression of the SIBLINGs and their MMP partners in human benign and malignant prostate neoplasms

Abstract